Bosh sahifaAIMI • OTCMKTS
add
AIM ImmunoTech Inc
Yopilish kursi
0,085 $
Kunlik diapazon
0,079 $ - 0,090 $
Yillik diapazon
0,025 $ - 0,12 $
Bozor kapitalizatsiyasi
6,13 mln USD
Oʻrtacha hajm
300,82 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 16,00 ming | -60,00% |
Joriy xarajat | 3,62 mln | -37,13% |
Sof foyda | -3,70 mln | 36,31% |
Sof foyda marjasi | -23,16 ming | -59,23% |
Har bir ulushga tushum | -0,05 | 58,33% |
EBITDA | -3,56 mln | 37,26% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,25 mln | -79,46% |
Jami aktivlari | 6,25 mln | -61,41% |
Jami passivlari | 10,10 mln | -11,07% |
Umumiy kapital | -3,86 mln | — |
Tarqatilgan aksiyalar | 76,42 mln | — |
Narxi/balansdagi bahosi | -1,70 | — |
Aktivlardan daromad | -121,80% | — |
Kapitaldan daromad | -6 371,48% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -3,70 mln | 36,31% |
Operatsiyalardan naqd pul | -2,36 mln | 50,97% |
Sarmoyadan naqd pul | 898,00 ming | 668,35% |
Moliyadan naqd pul | 660,00 ming | -76,67% |
Naqd pulning sof oʻzgarishi | -803,00 ming | 62,55% |
Boʻsh pul | -1,82 mln | 34,19% |
Haqida
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Tashkil etilgan
1966
Sayt
Xodimlar soni
22
